Related Experiment Videos
Mifepristone for luteal phase contraception
1Instituto Chileno de Medicina Reproductiva, José Ramón Gutiérrez 295 Apt. #3, Santiago Centro, Chile. hbcroxatto@icmer.org
Contraception
|December 31, 2003
Summary
Mifepristone shows potential for luteal phase contraception, effectively preventing pregnancy when used early in the luteal phase. However, its efficacy may be limited for reliable, long-term contraception compared to current methods.
Area of Science:
- Reproductive Endocrinology
- Pharmacology
Background:
- Luteal phase contraception aims to prevent pregnancy by targeting the post-ovulatory phase.
- Mifepristone, an antiprogestogen, has been investigated for its contraceptive potential.
Purpose of the Study:
- To review the concept of luteal phase contraception using mifepristone.
- To evaluate the efficacy and safety of mifepristone for pregnancy prevention and cycle regulation.
Main Methods:
- Review of clinical trials and pharmacological research on mifepristone.
- Analysis of data from emergency contraception studies and pilot clinical trials.
Main Results:
- Early luteal phase mifepristone administration effectively prevents pregnancy with minimal hormonal disruption.
- Mid and late luteal phase administration induces endometrial bleeding but does not reliably terminate established pregnancies.
Conclusions:
- Mifepristone demonstrates potential for early luteal phase contraception.
- Its partial agonistic properties may limit its ability to fully replace progesterone, impacting contraceptive efficacy compared to modern methods.